Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 30 results.
User Information
Export Records
  1. 1.   Structural and biochemical characterization of the inhibitor complexes of xenotropic murine leukemia virus-related virus protease
  2. Li, M.; Gustchina, A.; Matuz, K.; Tozser, J.; Namwong, S.; Goldfarb, N. E.; Dunn, B. M.; Wlodawer, A.
  3. Febs Journal. 2011, Nov; 278(22): 4413-4424.
  1. 2.   Crystal structures of the free and inhibited forms of plasmepsin I (PMI) from Plasmodium falciparum
  2. Bhaumik, P.; Horimoto, Y.; Xiao, H. G.; Miura, T.; Hidaka, K.; Kiso, Y.; Wlodawer, A.; Yada, R. Y.; Gustchina, A.
  3. Journal of Structural Biology. 2011, Jul; 175(1): 73-84.
  1. 3.   Foamy Retrovirus Integrase Contains a Pol Dimerization Domain Required for Protease Activation
  2. Lee, E. G.; Roy, J.; Jackson, D.; Clark, P.; Boyer, P. L.; Hughes, S. H.; Linial, M. L.
  3. Journal of Virology. 2011, Feb; 85(4): 1655-1661.
  1. 4.   Crystal structure of XMRV protease differs from the structures of other retropepsins
  2. Li, M.; DiMaio, F.; Zhou, D. W.; Gustchina, A.; Lubkowski, J.; Dauter, Z.; Baker, D.; Wlodawer, A.
  3. Nature Structural & Molecular Biology. 2011, Feb; 18(2): 227-229.
  1. 5.   Crystal Structures of Inhibitor Complexes of Human T-Cell Leukemia Virus (HTLV-1) Protease
  2. Satoh, T.; Li, M.; Nguyen, J. T.; Kiso, Y.; Gustchina, A.; Wlodawer, A.
  3. Journal of Molecular Biology. 2010, Aug; 401(4): 626-641.
  1. 6.   The Early Years of Retroviral Protease Crystal Structures
  2. Miller, M.
  3. Biopolymers. 2010 94(4): 521-529.
  1. 7.   Structural characterization of B and non-B subtypes of HIV-protease: Insights into the natural susceptibility to drug resistance development
  2. Sanches, M.; Krauchenco, S.; Martins, N. H.; Gustchina, A.; Wlodawer, A.; Polikarpov, I.
  3. Journal of Molecular Biology. 2007, Jun; 369(4): 1029-1040.
  1. 8.   Residue centrality, functionally important residues, and active site shape: Analysis of enzyme and non-enzyme families
  2. del Sol, A.; Fujihashi, H.; Amoros, D.; Nussinov, R.
  3. Protein Science. 2006, Sep; 15(9): 2120-2128.
  1. 9.   Chemical compound navigator: A web-based chem-BLAST, chemical taxonomy-based search engine for browsing compounds
  2. Prasanna, M. D.; Vondrasek, J.; Wlodawer, A.; Rodriguez, H.; Bhat, T. N.
  3. Proteins-Structure Function and Bioinformatics. 2006, Jun; 63(4): 907-917.
  1. 10.   Molecular replacement with pseudosymmetry and model dissimilarity: a case study
  2. Jaskolski, M.; Li, M.; Laco, G.; Gustchina, A.; Wlodawer, A.
  3. Acta Crystallographica Section D-Biological Crystallography. 2006, FEB; 62(Part 2): 208-215.
  1. 11.   Residues crucial for maintaining short paths in network communication mediate signaling in proteins
  2. del Sol, A.; Fujihashi, H.; Amoros, D.; Nussinov, R.
  3. Molecular Systems Biology. 2006
  1. 12.   Crystal structure of human T cell leukemia virus protease, a novel target for anticancer drug design
  2. Li, M.; Laco, G. S.; Jaskolski, M.; Rozycki, J.; Alexandratos, J.; Wlodawer, A.; Gustchina, A.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2005, Dec; 102(51): 18332-18337.
  1. 13.   Kinetics of the dimerization of retroviral proteases: The "fireman's grip" and dimerization
  2. Ingr, M.; Uhlikova, T.; Strisovsky, K.; Majerova, E.; Konvalinka, J.
  3. Protein Science. 2003 12(10): 2173-2182.
  1. 14.   Human immunodeficiency virus type 1 capsid protein is a substrate of the retroviral proteinase while integrase is resistant toward proteolysis
  2. Tozser, J.; Shulenin, S.; Kadas, J.; Boross, M.; Bagossi, M.; Copeland, T. D.; Nair, B. C.; Sarngadharan, M. G.; Oroszlan, S.
  3. Virology. 2003 310(1): 16-23.
  1. 15.   Molecular motions and conformational changes of HPPK
  2. Keskin, O.; Ji, X.; Blaszcyk, J.; Covell, D. G.
  3. Proteins-Structure Function and Genetics. 2002 49(2): 191-205.
  1. 16.   HIVdb: A database of the structures of human immunodeficiency virus protease
  2. Vondrasek, J.; Wlodawer, A.
  3. Proteins-Structure Function and Genetics. 2002 49(4): 429-431.
  1. 17.   A potent human immunodeficiency virus type 1 protease inhibitor, UIC-94003 (TMC-126), and selection of a novel (A28S) mutation in the protease active site
  2. Yoshimura, K.; Kato, R.; Kavlick, M. F.; Nguyen, A.; Maroun, V.; Maeda, K.; Hussain, K. A.; Ghosh, A. K.; Gulnik, S. V.; Erickson, J. W.; Mitsuya, H.
  3. Journal of Virology. 2002 76(3): 1349-1358.
  1. 18.   Point mutations and sequence variability in proteins. Redistributions of preexisting populations
  2. Sinha, N.; Nussinov, R.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2001 98(6): 3139-3144.
  1. 19.   Building blocks, hinge-bending motions and protein topology
  2. Sinha, N.; Tsai, C. J.; Nussinov, R.
  3. Journal of Biomolecular Structure & Dynamics. 2001 19(3): 369-380.
  1. 20.   Comparison of the substrate specificity of the human T-cell leukemia virus and human immunodeficiency virus proteinases
  2. Tozser, J.; Zahuczky, G.; Bagossi, P.; Louis, J. M.; Copeland, T. D.; Oroszlan, S.; Harrison, R. W.; Weber, I. T.
  3. European Journal of Biochemistry. 2000 267(20): 6287-6295.
  1. 21.   Structural and biochemical studies of retroviral proteases
  2. Wlodawer, A.; Gustchina, A.
  3. Biochimica et Biophysica Acta - Protein Structure & Molecular Enzymology. 2000 1477(1-2): 16-34.
  1. 22.   Protease inhibitors: resistance, cross-resistance, fitness and the choice of initial and salvage therapies
  2. Erickson, J. W.; Gulnik, S. V.; Markowitz, M.
  3. Aids. 1999 13(Suppl A): S189-S204.
  1. 23.   Stabilization from autoproteolysis and kinetic characterization of the human T-cell leukemia virus type 1 proteinase
  2. Louis, J. M.; Oroszlan, S.; Tozser, J.
  3. Journal of Biological Chemistry. 1999 274(10): 6660-6666.
  1. 24.   Effect of substrate residues on the P2 ' preference of retroviral proteinases
  2. Boross, P.; Bagossi, P.; Copeland, T. D.; Oroszlan, S.; Louis, J. M.; Tozser, J.
  3. European Journal of Biochemistry. 1999 264(3): 921-929.
  1. 25.   Drug resistance mutations can affect dimer stability of HIV-1 protease at neutral pH
  2. Xie, D.; Gulnik, S.; Gustchina, E.; Yu, B.; Shao, W.; Qoronfleh, W.; Nathan, A.; Erickson, J. W.
  3. Protein Science. 1999 8(8): 1702-1707.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel